Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01765205 · ClinicalTrials.gov registry record
Newborn Screening for Critical Congenital Heart Disease
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 20
- Enrollment target
NCT01765205 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 20 participants.
The verdict
NCT01765205 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
Previous studies have examined the usefulness of pulse oximetry or oxygen saturation to screen for left-sided cardiac lesions. These studies have shown that the occurrence of critical congenital cardiac malformations among asymptomatic newborns is high; the technique of pulse oximetry is reliable for detection of ductal dependant left-sided lesions, simple to operate(requires little time and can be done in the newborn nursery) and is cost effective; there is effective follow-up test (heart ultrasound) and available interventions have an effect on outcome for diagnosed newborns. The importance of this research project is to examine the overall helpfulness of measuring oximetry in newborn infants using somatic oximetry, as well ast to prepare for a population based study in the state of Florida.
Interventions
- DEVICE Pulse Oximetry using the INVOS (In Vivo Optical Spectroscopy) Cerebral/Somatic Oximeter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-03 |
| Est. Completion | 2014-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01765205
The ClinicalTrials.gov registry entry for NCT01765205 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pulse Oximetry using the INVOS (In Vivo Optical Spectroscopy) Cerebral/Somatic Oximeter is the first listed.
NCT01765205 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01765205 about?
NCT01765205 is a clinical study titled "Newborn Screening for Critical Congenital Heart Disease". Previous studies have examined the usefulness of pulse oximetry or oxygen saturation to screen for left-sided cardiac lesions. These studies have shown that the occurrence of critical congenital cardiac malformations among asymptomatic newborns is high; the technique of pulse oximetry is reliable fo...
What is the current status of trial NCT01765205?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2010-03. Estimated completion is 2014-01.
What interventions are being tested in trial NCT01765205?
The interventions under investigation include: Pulse Oximetry using the INVOS (In Vivo Optical Spectroscopy) Cerebral/Somatic Oximeter (DEVICE).
Who is sponsoring clinical trial NCT01765205?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.